Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Nuclear Medicine Communications|July 1, 1992
123I-methylene blue: an unsatisfactory parathyroid imaging agentP J Blower, A G Kettle, M J O'Doherty, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Targeting disseminated melanoma with radiolabelled methylene blue: Comparative bio-distribution studies in man and animalsE M Link, D C Costa, D Lui, et al.
European Journal of Nuclear Medicine|July 15, 1998
Design of hypoxia-targeting radiopharmaceuticals: selective uptake of copper-64 complexes in hypoxic cells in vitroJ L Dearling, J S Lewis, G E Mullen, et al.
Journal of Inorganic Biochemistry|May 30, 2001
Towards new transition metal-based hypoxic selective agents for therapy and imagingP J Blower, J R Dilworth, R I Maurer, et al.
Nuclear Medicine Communications|December 11, 1997
Pentavalent 99Tcm-DMSA imaging in patients with bone metastasesA S Lam, A G Kettle, M J O'Doherty, et al.
Nuclear Medicine Communications|January 1, 1993
Disposition of nebulized pentamidine measured using the direct radiolabel 123I-iodopentamidineM J O'Doherty, S H Thomas, C J Page, et al.
European Journal of Nuclear Medicine|June 10, 1998
Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studiesP J Blower, A S Lam, M J O'Doherty, et al.
Nuclear Medicine Communications|March 1, 1993
Studies on the preparation and isomeric composition of 186Re- and 188Re-pentavalent rhenium dimercaptosuccinic acid complexJ Singh, K Reghebi, C R Lazarus, et al.
European Journal of Nuclear Medicine|July 7, 2001
In vivo evaluation of 111In-DTPA-N-TIMP-2 in Kaposi sarcoma associated with HIV infectionR Kulasegaram, B Giersing, C J Page, et al.
Pageof 5